Argos Wealth Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$305K Buy
3,859
+93
+2% +$7.91K 0.08% 147
2026
Q1
$324K Sell
3,766
-1,291
-26% -$116K 0.09% 125
2025
Q4
$442K Buy
+5,057
New +$384K 0.12% 99

Other funds holding GMED

Argos Wealth Advisors's GMED Position: Q2 2026 in Review

Argos Wealth Advisors increased its Globus Medical (GMED) stake by 2.5% in Q2 2026, buying an estimated $7.91K and bringing the position to 3,859 shares worth $305K. The position accounts for 0.08% of the portfolio, ranked #147.

Argos Wealth Advisors first reported a position in GMED in Q4 2025 and has held it in 3 quarters since. The position peaked at $442K in Q4 2025. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Argos Wealth Advisors held 3,859 shares of Globus Medical worth $305K as of Q2 2026.
  • Argos Wealth Advisors bought 93 Globus Medical shares in Q2 2026, an estimated $7.91K.
  • Globus Medical made up 0.08% of Argos Wealth Advisors's portfolio in Q2 2026, its #147 holding.
  • Argos Wealth Advisors first reported a position in Globus Medical in Q4 2025 and has held it in 3 quarters since.
  • Argos Wealth Advisors's Globus Medical position peaked at $442K in Q4 2025.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Argos Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.